These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2124530)

  • 21. Progressive systemic sclerosis and renal transplantation: a contraindication to the use of cyclosporine A?
    Ruiz JC; Val F; de Francisco AL; de Bonis E; Zubimendi JA; Prieto M; Canga E; Sanz de Castro S; Arias M
    Transplant Proc; 1991 Aug; 23(4):2211-2. PubMed ID: 1871849
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunosuppressive and cytotoxic drugs in the treatment of rheumatic skin disorders.
    Callen JP
    Semin Cutan Med Surg; 2001 Mar; 20(1):58-68. PubMed ID: 11308138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term therapy of immunologic diseases with special reference to the use of immunosuppressive agents].
    Scheiffarth F; Warnatz H
    Dtsch Med Wochenschr; 1969 Nov; 94(47):2444-9. PubMed ID: 4310731
    [No Abstract]   [Full Text] [Related]  

  • 24. [Do the interferons have an antifibrotic action? The internist's point of view].
    Blétry O; Somogyi A
    Rev Med Interne; 2002 Nov; 23 Suppl 4():511s-515s. PubMed ID: 12481407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporin in localized and systemic scleroderma--a clinical study.
    Wörle B; Hein R; Krieg T; Meurer M
    Dermatologica; 1990; 181(3):215-20. PubMed ID: 2269381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Contribution of immunology to the treatment of multiple sclerosis].
    Pérez-Miranda J; Parrilla-Ramírez JL
    Rev Neurol; 1998 Jul; 27(155):117-21. PubMed ID: 9674043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of DMARDs in systemic sclerosis therapy.
    Blank N; Max R; Lorenz HM
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii42-4. PubMed ID: 16987834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Indications for immunosuppressive treatment in kidney diseases of children].
    Wojnarowski M; Wyszyńska T
    Pediatr Pol; 1969 May; 44(5):525-30. PubMed ID: 4183009
    [No Abstract]   [Full Text] [Related]  

  • 29. [Systemic sclerosis].
    Gustafsson R
    Nord Med; 1994; 109(8-9):236-7. PubMed ID: 7937033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current treatment of systemic sclerosis. Part I. Immunosuppressive treatment].
    Sicińska J; Rudnicka L
    Pol Merkur Lekarski; 2008 Aug; 25(146):192-5. PubMed ID: 18942346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of systemic sclerosis with gamma-interferon.
    Hein R; Behr J; Hündgen M; Hunzelmann N; Meurer M; Braun-Falco O; Urbanski A; Krieg T
    Br J Dermatol; 1992 May; 126(5):496-501. PubMed ID: 1610690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunosuppressive therapy in clinical practice].
    Frey FJ
    Schweiz Med Wochenschr; 1987 May; 117(21):810-5. PubMed ID: 3589636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of overlap syndrome of PSS, SLE and Sjögren syndrome treated by cyclosporin A: an improvement of sclerosis of the skin].
    Kume A; Ueda K; Sano S; Funai T; Kobayashi Y; Hashimoto K; Yoshikawa K
    Nihon Hifuka Gakkai Zasshi; 1989 Oct; 99(11):1191-6. PubMed ID: 2614988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of interferon-gamma on experimental scleroderma induced by bleomycin.
    Yamamoto T; Takagawa S; Kuroda M; Nishioka K
    Arch Dermatol Res; 2000 Jul; 292(7):362-5. PubMed ID: 10966061
    [No Abstract]   [Full Text] [Related]  

  • 35. [Drug therapy of vasculitis with immunosuppressive agents, immunomodulators and cyclosporin A].
    Abe C
    Nihon Rinsho; 1985 Oct; 43(10):2196-9. PubMed ID: 3912547
    [No Abstract]   [Full Text] [Related]  

  • 36. Toward rational treatment of scleroderma.
    Freundlich B
    Hosp Pract (Off Ed); 1993 Sep; 28(9A):8, 13-4. PubMed ID: 8408363
    [No Abstract]   [Full Text] [Related]  

  • 37. Cytotoxic therapy in systemic lupus erythematosus. Experience from a single center.
    Rahman P; Humphrey-Murto S; Gladman DD; Urowitz MB
    Medicine (Baltimore); 1997 Nov; 76(6):432-7. PubMed ID: 9413429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combination of antimetabolites and alkylating agents in the treatment of advanced breast cancer].
    Germiniani R; Pipino G; Lavorato F; Bressani Doldi S
    Minerva Med; 1977 Mar; 68(13):831-4. PubMed ID: 321989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporin A treatment of systemic sclerosis.
    Zachariae H; Halkier-Sørensen L; Heickendorff L; Zachariae E; Hansen HE
    Br J Dermatol; 1990 May; 122(5):677-81. PubMed ID: 2354119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung fibrosis in systemic sclerosis treated with a combination of ciclosporin and azathioprine.
    Hider SL; Woodhead M; Taylor PM; Bruce IN
    Clin Exp Rheumatol; 2006; 24(2):215. PubMed ID: 16762168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.